Impaired reinnervation in HIV infection following experimental denervation

Neurology

Volumn 68, Issue 16, 2007, Pages 1251-1256

  Hahn, K ^a,b   Triolo, A ^d   Hauer, P ^a   McArthur, J C ^a   Polydefkis, M ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER TRANSECTION; NERVE REGENERATION; NERVE SPROUTING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSORY NEUROPATHY; SKIN BIOPSY; VALIDATION PROCESS; VOLUNTEER;

ADULT; ANALGESICS, NON-NARCOTIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; CAPSAICIN; DENERVATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HIV INFECTIONS; HUMANS; MALE; NERVE REGENERATION; PERIPHERAL NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; RECEPTORS, SENSORY; SKIN;

EID: 34247222192     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000261245.36884.7c     Document Type: Article

References (24)

1. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Periph Nerv Syst 2001;6:8-13.
2. Brinley FJ Jr, Pardo CA, Verma A. Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol 2001;58:1561-1566.
3. Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 2004;61:546-551.
4. Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002;58:1764-1768.
5. Corder EH, Robertson K, Lannfelt L, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998;4:1182-1184.
6. Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 2000;57:1561-1565.
7. Blum AS, Dal Pan GJ, Feinberg J, et al. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors. Neurology 1996;46:999-1003.
8. Polydefkis M, Yiannoutsos CT, Cohen BA, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002;58:115-119.
9. Rajan B, Polydefkis M, Hauer P, Griffin JW, McArthur JC. Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol 2003;457:24-36.
10. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004;127:1606-1615.
11. Hahn K, Sirdofsky M, Brown A, et al. Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy. J Periph Nerv Syst 2006;11:142-147.
12. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: validation and reliability study. Neurology 1999;53:1660-1664.
13. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-1855.
14. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998;55:1513-1520.
15. Herrmann DN, McDermott MP, Henderson D, Chen L, Akowuah K, Schifitto G. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve 2004;29:420-427.
16. Chapman J, Estupinan J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein E genotype determination. Neurology 1996;46:1484-1485.
17. Bradley WG, Shapshak P, Delgado S, Nagano I, Stewart R, Rocha B. Morphometric analysis of the peripheral neuropathy of AIDS. Muscle Nerve 1998;21:1188-1195.
18. Lauria G, Morbin M, Lombardi R, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003;61:631-636.
19. Herrmann DN, McDermott MP, Sowden JE, et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study. Neurology 2006;66:857-861.
20. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004;146:477-492.
21. Zhou Z, Hoke A, Cornblath DR, Griffin JW, Polydefkis M. APOE epsilon4 is not a susceptibility gene in idiopathic or diabetic sensory neuropathy. Neurology 2005;64:139-141.
22. Fullerton SM, Clark AG, Weiss KM, et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 2000;67:881-900.
23. Moore RD, Wong WM, Keruly JC, McArthur JC. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 2000;14:273-278.
24. Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function. J Neurosci 1998;18:8947-8959.